Alfredas B.
- Country
- Lithuania
- Department
- N/A
Research Overview
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Study Evaluating Efficacy and Safety of Lunsekimig in Adults with Inadequately Controlled Eosinophilic COPD
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Long-term Safety and Tolerability Evaluation of Itepekimab in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Data & Insights
Has run more than one trial at 104 of 637 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in treating chronic obstructive pulmonary disease (COPD), with particular focus on managing moderate to severe cases and evaluating innovative therapeutic approaches. Their research extends to studying long-term treatment outcomes and exacerbation prevention in former smokers.
- COPD management
- Respiratory therapeutics
- Exacerbation prevention
Infectious Diseases
The investigator has expertise in treating complicated urinary tract infections and community-acquired pneumonia. Their work includes evaluation of novel antimicrobial therapies and management of COVID-19 pneumonia, particularly focusing on moderate to severe cases.
- Urinary tract infections
- Pneumonia treatment
- COVID-19 management
Cardiovascular Medicine
The investigator focuses on preventing stroke and systemic embolism in patients with atrial fibrillation. Their expertise includes evaluation of anticoagulation therapies and management of stroke risk in cardiac patients.
- Stroke prevention
- Atrial fibrillation management
- Anticoagulation therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.